Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Hansa Biopharma Plans Restructuring | Contract Pharma
Breaking News

Hansa Biopharma Plans Restructuring

Aims to optimize resources and improve operational efficiency.

Hansa Biopharma AB, which appointed a new CEO and COO earlier this year, has announced plans to restructure its organization to optimize resource allocation and improve operational efficiency. The planned restructuring would result in an approximately 20% reduction in the current workforce and would result in projected annual savings of 40-50 million Swedish krona. The restructuring is subject to negotiation with relevant trade unions.

Renée Aguiar-Lucander, CEO, Hansa Biopharma said: “This planned restructuring is a strategic decision to optimize resources and improve operational efficiency at a critical time for the organization. We anticipate this will lead to cost savings as well as increased efficiency, transparency and accountability throughout the organization. We are confident that these changes are necessary and will position us to more effectively deliver value to shareholders and patients.”

As part of the restructuring, Hansa will notify the Swedish Public Employment Service and seek consultations with the trade unions regarding the reorganization. Decisions regarding employee reductions will take place after the change consultations have been concluded, according to local regulations.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters